Manufacturer of Controlled Substances; Notice of Application, 18570 [E8-7039]

Download as PDF 18570 Federal Register / Vol. 73, No. 66 / Friday, April 4, 2008 / Notices Maps appearing here in the comment are illegible upon reprinting. The maps are available at the Department of Justice Antitrust Division, 325 Seventh Street, NW., Room 215, Washington, DC 20530, (202) 514–2481, and at the Office of the Clerk of the United States District Court for the District of Columbia, 333 Constitution Avenue, NW., Washington, DC 20001. made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug Schedule Tetrahydrocannabinols (7370) ..... Methylphenidate (1724) ................ Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Oripavine (9330) ........................... Thebaine (9333) ........................... Oxymorphone (9652) ................... Noroxymorphone (9668) .............. Fentanyl (9801) ............................ I II II II II II II II II II II II controlled substances listed in schedules I and II: Drug Dihydromorphine (9145) ............... Amphetamine (1100) .................... Methylphenidate (1724) ................ Amobarbital (2125) ....................... Pentobarbital (2270) ..................... Secobarbital (2315) ...................... Glutethimide (2550) ...................... Codeine (9050) ............................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Methadone (9250) ........................ Methadone intermediate (9254) ... Dextropropoxyphene, bulk (nondosage forms) (9273). Morphine (9300) ........................... Oxymorphone (9652) ................... Schedule I II II II II II II II II II II II II II North Lamar County Citizens Association P.O. Box 516, Milner, Georgia 30257. ‘‘Quality Growth, Quality Life’’ January 14, 2008. Maribeth Petrizzi, Chief, Litigation II Section, Antitrust Division, U.S. Department of Justice, 1401 H Street NW., Suite 3000, Washington, DC 20530. Supplement To Comment Re: USA DOJ v. Vulcan Materials Company and Florida Rock Industries, Inc., Case: I:07–cv–02044. Dear Ms. Petrizzi, After sending our comment I realized there was no contact information included. Accordingly, below is my contact information. Also attached are photos showing that FRI has already begun working at the Lamar County Quarry. If you have any questions, please feel free to call me. Sincerely, Jonathan P. Sexton President, North Lamar County Citizens Association Contact: Jonathan P. Sexton. Phone: 770–474–9335. Fax: 770–474–7113. E-mail: jonsclerk@yahoo.com. Photographs appearing here in the comment are illegible upon reprinting. The photographs are available at the Department of Justice Antitrust Division, 325 Seventh Street, NW., Room 215, Washington, DC 20530, (202) 514–2481, and at the Office of the Clerk of the United States District Court for the District of Columbia, 333 Constitution Avenue, NW., Washington, DC 20001. The company plans to manufacture the listed controlled substances in bulk for conversion and sale to dosage form manufacturers. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), Washington, DC 20537, or any being sent via express mail should be sent to Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than June 3, 2008. The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), Washington, DC 20537, or any being sent via express mail should be sent to Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than June 3, 2008. Dated: March 28, 2008. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E8–7037 Filed 4–3–08; 8:45 am] Dated: March 28, 2008. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E8–7039 Filed 4–3–08; 8:45 am] BILLING CODE 4410–09–P BILLING CODE 4410–09–P [FR Doc. E8–6875 Filed 4–3–08; 8:45 am] DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Executive Office for Immigration Review DEPARTMENT OF JUSTICE Manufacturer of Controlled Substances; Notice of Application [OMB Number 1125–0003] Drug Enforcement Administration Pursuant to 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 10, 2008, Siegfried (USA), Inc., Industrial Park Road, Pennsville, New Jersey 08070, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of Agency Information Collection Activities: Proposed Collection; Comments Requested ebenthall on PRODPC61 with NOTICES BILLING CODE 4410–11–C Manufacturer of Controlled Substances; Notice of Application Pursuant to 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 5, 2008, Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816, VerDate Aug<31>2005 15:24 Apr 03, 2008 Jkt 214001 PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 II II 60-day notice of information collection under review: fee waiver request. ACTION: The Department of Justice (DOJ), Executive Office for Immigration E:\FR\FM\04APN1.SGM 04APN1

Agencies

[Federal Register Volume 73, Number 66 (Friday, April 4, 2008)]
[Notices]
[Page 18570]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-7039]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 10, 2008, Siegfried 
(USA), Inc., Industrial Park Road, Pennsville, New Jersey 08070, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Dihydromorphine (9145).....................  I
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Amobarbital (2125).........................  II
Pentobarbital (2270).......................  II
Secobarbital (2315)........................  II
Glutethimide (2550)........................  II
Codeine (9050).............................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
Methadone (9250)...........................  II
Methadone intermediate (9254)..............  II
Dextropropoxyphene, bulk (non-dosage forms)  II
 (9273).
Morphine (9300)............................  II
Oxymorphone (9652).........................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration pursuant to 21 CFR 
1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Drug Enforcement 
Administration, Office of Diversion Control, Federal Register 
Representative (ODL), Washington, DC 20537, or any being sent via 
express mail should be sent to Drug Enforcement Administration, Office 
of Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than June 3, 2008.

    Dated: March 28, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E8-7039 Filed 4-3-08; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.